Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$7.21 - $10.49 $108,150 - $157,350
-15,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$8.48 - $13.61 $782,704 - $1.26 Million
-92,300 Reduced 86.02%
15,000 $144,000
Q1 2021

May 17, 2021

SELL
$12.96 - $19.75 $553,392 - $843,325
-42,700 Reduced 28.47%
107,300 $1.46 Million
Q4 2020

Feb 16, 2021

SELL
$12.74 - $18.49 $1.09 Million - $1.58 Million
-85,294 Reduced 36.25%
150,000 $2.15 Million
Q3 2020

Nov 16, 2020

BUY
$5.86 - $18.47 $521,446 - $1.64 Million
88,984 Added 60.82%
235,294 $4.35 Million
Q4 2019

Feb 14, 2020

BUY
$4.71 - $5.4 $689,120 - $790,074
146,310 New
146,310 $783,000

Others Institutions Holding TFFP

# of Institutions
1
Shares Held
1M
Call Options Held
0
Put Options Held
0

About TFF Pharmaceuticals, Inc.


  • Ticker TFFP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,477,800
  • Market Cap $8.92M
  • Description
  • TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...
More about TFFP
Track This Portfolio

Track Precept Management LLC Portfolio

Follow Precept Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Precept Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Precept Management LLC with notifications on news.